Search research articles
Contact Us
Filters
Showing results (421-430 of 504) with videos related to
Page
of 51
Sort By:
Prostate Cancer and Prostatic Diseases
|
October 16, 2019
A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer
Ashley E Ross, Paula J Hurley, Phuoc T Tran, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 14, 2017
Predictive Value of <sup>18</sup>F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib
Rudolf A Werner, Jan-Stefan Schmid, Takahiro Higuchi, et al.
Nuclear Medicine Communications
|
February 22, 2023
Wnt/β-catenin modulating drugs regulate somatostatin receptor expression and internalization of radiolabelled octreotide in neuroendocrine tumor cells
Alexander Weich, Dorothea Rogoll, Melissa Peschka, et al.
Annals of Nuclear Medicine
|
October 26, 2017
Low levels of PSMA expression limit the utility of <sup>18</sup>F-DCFPyL PET/CT for imaging urothelial carcinoma
Scott P Campbell, Alexander S Baras, Mark W Ball, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 17, 2018
Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms
Roberto A Salas Fragomeni, Tali Amir, Sara Sheikhbahaei, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 28, 2019
Prospective Comparison of PET Imaging with PSMA-Targeted <sup>18</sup>F-DCFPyL Versus Na<sup>18</sup>F for Bone Lesion Detection in Patients with Metastatic Prostate Cancer
Steven P Rowe, Xin Li, Bruce J Trock, et al.
BJU International
|
September 23, 2024
The use of <sup>99m</sup>Tc-tetrofosmin in the characterisation of indeterminate renal masses: a pilot study
Ergi Spiro, Salikh Murtazaliev, Alireza Amindarolzarbi, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 3, 2017
Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging
Sara Sheikhbahaei, Ali Afshar-Oromieh, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 7, 2024
Prognostic Performance of RECIP 1.0 Based on [<sup>18</sup>F]PSMA-1007 PET in Prostate Cancer Patients Treated with [<sup>177</sup>Lu]Lu-PSMA I&T
Philipp E Hartrampf, Thomas Hüttmann, Anna Katharina Seitz, et al.
Clinical Nuclear Medicine
|
February 15, 2019
Novel Functional Renal PET Imaging With 18F-FDS in Human Subjects
Rudolf A Werner, Alvaro A Ordonez, Julian Sanchez-Bautista, et al.
Page
of 51
Search research articles
Search
Showing results (421-430 of 504) with videos related to
Sort By:
Page
of 51
Prostate Cancer and Prostatic Diseases
|
October 16, 2019
A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer
Ashley E Ross, Paula J Hurley, Phuoc T Tran, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 14, 2017
Predictive Value of <sup>18</sup>F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib
Rudolf A Werner, Jan-Stefan Schmid, Takahiro Higuchi, et al.
Nuclear Medicine Communications
|
February 22, 2023
Wnt/β-catenin modulating drugs regulate somatostatin receptor expression and internalization of radiolabelled octreotide in neuroendocrine tumor cells
Alexander Weich, Dorothea Rogoll, Melissa Peschka, et al.
Annals of Nuclear Medicine
|
October 26, 2017
Low levels of PSMA expression limit the utility of <sup>18</sup>F-DCFPyL PET/CT for imaging urothelial carcinoma
Scott P Campbell, Alexander S Baras, Mark W Ball, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 17, 2018
Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms
Roberto A Salas Fragomeni, Tali Amir, Sara Sheikhbahaei, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 28, 2019
Prospective Comparison of PET Imaging with PSMA-Targeted <sup>18</sup>F-DCFPyL Versus Na<sup>18</sup>F for Bone Lesion Detection in Patients with Metastatic Prostate Cancer
Steven P Rowe, Xin Li, Bruce J Trock, et al.
BJU International
|
September 23, 2024
The use of <sup>99m</sup>Tc-tetrofosmin in the characterisation of indeterminate renal masses: a pilot study
Ergi Spiro, Salikh Murtazaliev, Alireza Amindarolzarbi, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 3, 2017
Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging
Sara Sheikhbahaei, Ali Afshar-Oromieh, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 7, 2024
Prognostic Performance of RECIP 1.0 Based on [<sup>18</sup>F]PSMA-1007 PET in Prostate Cancer Patients Treated with [<sup>177</sup>Lu]Lu-PSMA I&T
Philipp E Hartrampf, Thomas Hüttmann, Anna Katharina Seitz, et al.
Clinical Nuclear Medicine
|
February 15, 2019
Novel Functional Renal PET Imaging With 18F-FDS in Human Subjects
Rudolf A Werner, Alvaro A Ordonez, Julian Sanchez-Bautista, et al.
Page
of 51